Circadian changes in pharmacokinetics of cyclosporin in healthy volunteers.

被引：0
|
作者：
Choi, JS [1 ]
Park, HJ [1 ]
机构：
[1] Chosun Univ, Coll Pharm, Dong Gu, Kwangju 501759, South Korea
来源：
RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY | 1999年 / 103卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Circadian changes in the pharmacokinetics of cyclosporin were evaluated after oral administration of the drug, 300 mg, at 09:00 and 20:00 to twelve healthy male subjects. At 09:00, the blood concentrations of cyclosporin were higher, the area under the blood concentration-time curve from time 0 to time infinity was significantly greater (9.70 versus 8.42 mu g.hr/ml), and the renal clearance was significantly slower (1.14 versus 1.48 ml/min) than those at 22:00. The terminal half-life, peak concentration, and time to reach peak concentration were not significantly different between two groups.
引用
收藏
页码：109 / 112
页数：4
相关论文
共 50 条
  • [41] The effects of alcohol on the pharmacokinetics, safety, and tolerability of udenafil in healthy male volunteers.
    Jung, J. A.
    Ghim, J. L.
    Cho, S. H.
    Choe, S. M.
    Kim, U. J.
    Lim, H. S.
    Bae, K. S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S27 - S28
  • [42] PHARMACOKINETICS OF SINGLE AND MULTIPLE DOSES OF PITAVASTATIN CALCIUM IN CHINESE HEALTHY VOLUNTEERS.
    Feng, P.
    Gu, J.
    Luo, Z.
    Zhang, Y.
    Gou, Z.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S116 - S116
  • [43] Effect of food on the pharmacokinetics of rifalazil, a novel antibacterial, in healthy male volunteers.
    Chen, Y
    Robertson, L
    Carlson, J
    Kivel, N
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P44 - P44
  • [44] Pharmacokinetics of intravenous d- and L-methamphetamine in healthy volunteers.
    Uemura, N
    Harris, D
    Nath, RP
    Fernandez, E
    Jacob, P
    Everhart, ET
    Jones, RT
    Men-Delson, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P37 - P37
  • [45] EFFECT OF SINGLE- DOSE RIFAMPIN ON THE PHARMACOKINETICS OF WARFARIN IN HEALTHY VOLUNTEERS.
    Frymoyer, A.
    Shugarts, S.
    Browne, M.
    Wu, A. H.
    Frassetto, L.
    Benet, L. Z.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S4 - S4
  • [46] Pharmacokinetics of multiple escalating doses of GBR12909 in healthy volunteers.
    Tandon, V
    Rajagopalan, P
    Cherstniakova, SA
    Chiang, N
    Vocci, F
    Elkashef, A
    Mojsiak, J
    Haigney, M
    Cantilena, LR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P61 - P61
  • [47] EFFECT OF ESOMEPRAZOLE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF SMC021 IN HEALTHY VOLUNTEERS.
    Choi, L.
    Sivasubramanian, R.
    Bhad, P.
    Junker, U.
    Jones, J.
    Azria, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S125 - S125
  • [48] Pharmacodynamics of octreotide in healthy volunteers.
    Pyke, R
    Foschia, S
    Siletti, S
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (02) : PII25 - PII25
  • [49] PHARMACOKINETICS AND PHARMACODYNAMICS OF PT302, A LONG ACTING EXENATIDE, IN HEALTHY VOLUNTEERS.
    Shin, D.
    Gu, N.
    Yoon, S.
    Seol, E.
    Lee, H.
    Lim, K.
    Jang, I.
    Shin, S.
    Yu, K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S43 - S43
  • [50] Disposition of desloratadine in healthy volunteers.
    Reyderman, L
    Ramanathan, R
    Chowdhury, S
    Alton, K
    Statkevich, P
    Wirth, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P48 - P48
12345